Aurora Cannabis (ACB) Investment Income (2017 - 2018)
Aurora Cannabis (ACB) posted quarterly Investment Income of -$2.5 million for Q3 2018, down 77988.94% year-over-year from N/an in Q3 2017, and down 77988.94% quarter-over-quarter from -$3189.6 in Q3 2017.
Aurora Cannabis (ACB) Investment Income (2017 - 2018) Analysis & Trends
Aurora Cannabis (ACB) has reported Investment Income for 2 consecutive years, with -$2.5 million the latest figure, recorded in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inv. Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Aurora Cannabis | 233.15 Mn | 160.83 Mn | 25.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | -2.49 Mn |
| Sep 30, 2017 | -3,189.63 |